Article Versions Notes

Kessler C, Ruschil C, Abdelhak A, Wilke C, Maleska A, Kuhle J, Krumbholz M, Kowarik MC, Schüle R. Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4. International Journal of Molecular Sciences. 2022; 23(21):13466. https://doi.org/10.3390/ijms232113466

Kessler, Christoph, Christoph Ruschil, Ahmed Abdelhak, Carlo Wilke, Aleksandra Maleska, Jens Kuhle, Markus Krumbholz, Markus C. Kowarik, and Rebecca Schüle. 2022. "Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4" International Journal of Molecular Sciences 23, no. 21: 13466. https://doi.org/10.3390/ijms232113466

Kessler, C., Ruschil, C., Abdelhak, A., Wilke, C., Maleska, A., Kuhle, J., Krumbholz, M., Kowarik, M. C., & Schüle, R. (2022). Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4. International Journal of Molecular Sciences, 23(21), 13466. https://doi.org/10.3390/ijms232113466